Home
>
Stock Market
>
>
Iol Chemicals And Pharmaceuticals Ltd

Iol Chemicals And Pharmaceuticals Ltd share price and stock overview

Iol Chemicals And Pharmaceuticals Ltd (NSE: IOLCP, BSE: 524164) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE485C01029 and a face value of Rs 2. As of 25 October 2026, it trades at Rs (164.14) with a market capitalisation of Rs 4796.24 crore. Figures are live and subject to change.

Iol Chemicals And Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

NSE BSE

164.14 -7.22 (-4.21%) downArrowC

As on: 25-Oct-2026 , 07:23 AM

Market Cap(₹Cr) 4796.24

Book Value(₹Cr) 61.2676986

BSE Code : 524164 NSE Symbol : IOLCP EPS(TTM) : 6.02 ISIN Demat : INE485C01029 P/E(TTM) : 27.14 Face Value(₹) : 2 Div & Yield % : 0.61

Today Market

Stock Performance

Today Market

Today's High

73,766.51

Todday's Low

72,452.37

Open at

73,665.64

Previous Close

73,249.39

Volumes

Avg Price

-125.56

Historical Performance

News

07 Oct 26

IOL Chemicals and Pharmaceuticals reports certificate compliance with SEBI regulations

IOL Chemicals and Pharmaceuticals Limited informed the National Stock Exchange of India Ltd.

25 Sep 26

IOL Chemicals restricts trading for insiders ahead of September 2026 financial results

IOL Chemicals and Pharmaceuticals Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026, in compliance with SEBI regulations.

10 Aug 26

IOL Chemicals & Pharmaceuticals Ltd consolidated sales up 22.09% on year in Q2FY2026, net profit surged by 21.14%

IOL Chemicals & Pharmaceuticals Ltd share price gained 2.85% to Rs 167.8 after the company's net profit jumped 21.

03 Aug 26

IOL Chemicals board to review quarterly results and close trading window

IOL Chemicals and Pharmaceuticals Limited will hold a board meeting on Monday, August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and the trading window for designated persons will remain closed until August 13, 2026, as per SEBI regulations.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
23-10-26	169.20	170.90	160.55	164.14	3110556	42716	512058778.58	22600.00
22-10-26	172.10	176.83	168.00	171.36	3036755	48943	522578508.04	22687.65
21-10-26	183.24	184.84	171.60	174.24	3097525	52500	547199892.10	22811.35
19-10-26	194.68	194.68	181.21	183.13	2060685	34312	384371541.45	22888.95
16-10-26	196.00	198.00	191.00	194.69	1875426	27918	364162583.51	23146.15
15-10-26	202.80	202.80	193.25	195.08	1361304	19562	268280406.76	22997.35
14-10-26	193.98	204.30	193.70	203.69	2356684	34499	473480414.84	22622.70
13-10-26	196.75	196.77	188.61	195.11	2545371	33410	491479670.32	22721.95
12-10-26	202.00	205.75	195.63	198.66	1719358	26073	346608583.14	22363.35
09-10-26	206.10	211.00	199.38	201.15	2768843	35202	566595871.87	22520.45

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

4796.24

PE Ratio

27.14

PB Ratio

2.67

Dividend Yield

0.61

ROE

7.90

ROCE

10.60

Book Value (₹)

61.2676986

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

0.00

Indian

Bodies Corporate-Indian (Promoter & Group)	176815175	60.24	176815175	3
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	5984825	2.04	5984825	2
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

182800000

62.28

182800000

Total ShareHolding for Promoter & Group

182800000

62.28

182800000

Publice Share Holding

Institution

Government(Central / State)	2000	0.00	2000	1
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	0	0.00	0	0
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	21288290	7.25	21288290	86
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	0	0.00	0	0
Mutual Funds / UTI	849399	0.29	798399	7
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	35816	0.01	35816	4
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

22175505

7.55

22124505

Non Institution

Bodies Corporate	3904430	1.33	3888930	391
Clearing Members	178126	0.06	178126	32
Directors & their Relatives	0	0.00	0	0
Employees	40959	0.01	40959	107
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	4029678	1.37	4029678	2143
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	3145094	1.07	3145094	2295
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	12930015	4.41	12930015	39
Individuals holding nominal share capital up to Rs. 1 lakh	63034294	21.47	60939669	127057
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	225199	0.08	225199	4
Others	40920	0.01	40920	2

Sub Total

88552005

30.17

86441880

132138

Total Public Shareholding

110727510

37.72

108566385

132236

Total of Promoter & Public ShareHolding

293527510

100.00

291366385

132241

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

293527510

100.00

291366385

132241

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Net Sales	2,319.06	2,079.21	2,132.79	2,217.11
OPM (%)	8.43	6.64	8.52	8.51
OP	195.57	137.96	181.65	188.65
Other Income	21.38	22.41	30.07	25.61
PBIDT	279.14	224.71	260.66	251.28
INTEREST	14.55	14.76	16.10	16.47
PBDT	264.59	209.95	244.56	234.81
PBT	173.15	137.96	181.65	188.65
EO	-11.21	0.00	0.00	0.00
PBT after EO	184.36	137.96	181.65	188.65
TAXES	46.72	36.89	47.22	49.51
PAT	137.64	101.07	134.43	139.14
EPS	4.69	3.44	4.58	23.70
Raw Material	64.75	65.33	67.29	69.28
Power and Fuel	6.68	5.53	6.99	5.95
Employee Cost	10.71	10.42	9.43	7.59
Other Manufacturing Expenses	0.00	0.00	0.00	0.00
Selling and Administration Expenses	2.63	3.38	2.83	3.08
Miscellaneous Expenses	1.72	1.72	2.22	1.47
Revenue (Growth %)	11.54	-2.51	-3.80	1.52
PBIDT (Growth %)	24.22	-13.79	3.73	-9.09
PAT (Growth %)	36.18	-24.82	-3.39	-17.02
PBIDT (Margin %)	12.04	10.81	12.22	11.33
PAT (Margin %)	5.94	4.86	6.30	6.28

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	58.71	58.71	58.71	58.71	58.71	58.71
Reserves Total	1739.67	1628.70	1552.62	1447.84	1331.56	1201.72
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	1798.38	1687.41	1611.33	1506.55	1390.27	1260.43
Secured Loans	0.00	117.04	32.76	79.63	42.75	0.00
Unsecured Loans	135.42	0.00	0.00	0.18	1.20	2.73
Total Debt	135.42	117.04	32.76	79.81	43.95	2.73
Other Liabilities	10.96	6.69	6.75	1.79	3.26	4.06
Total Liabilities	1944.76	1811.14	1650.84	1588.15	1437.48	1267.22
APPLICATION OF FUNDS :
Gross Block	1631.55	1543.74	1235.58	994.71	761.99	676.81
Less : Accumulated Depreciation	450.29	373.40	302.89	243.40	201.35	164.45
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1181.26	1170.34	932.69	751.31	560.64	512.36
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	95.54	21.93	100.87	89.64	105.20	48.27
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	21.12	21.01	20.59	20.27	2.47	1.22
Current Assets, Loans & Advances
Inventories	371.07	360.62	424.84	325.52	409.89	295.15
Sundry Debtors	603.13	513.69	471.23	505.28	469.80	300.31
Cash and Bank Balance	198.25	207.94	142.62	20.90	137.88	364.74
Loans and Advances	51.55	65.57	77.91	64.81	58.77	48.48
Total Current Assets	1224.00	1147.82	1116.60	916.51	1076.34	1008.68
Less : Current Liabilities and Provisions
Current Liabilities	551.33	490.86	523.60	367.97	462.29	278.93
Provisions	5.77	1.97	3.39	8.13	7.34	10.72
Total Current Liabilities & Provisions	557.10	492.83	526.99	376.10	469.63	289.65
Net Current Assets	666.90	654.99	589.61	540.41	606.71	719.03
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	6.96	4.97	4.56	3.97	2.91	2.54
Deferred Tax Liability	91.82	82.78	70.70	60.33	56.09	55.76
Net Deferred Tax	-84.86	-77.81	-66.14	-56.36	-53.18	-53.22
Other Assets	64.80	20.68	73.22	242.88	215.64	39.56
Total Assets	1944.76	1811.14	1650.84	1588.15	1437.48	1267.22
Contingent Liabilities	5.66	5.52	6.08	5.35	0.18	0.52

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	-1.64	-4.11	-92.50	46.04	-29.03
Investing Activities	-120.62	-119.19	-191.39	-154.23	-198.12
Net Cash Flow	-31.22	-0.16	6.57	70.49	-12.73
Operating Activities	91.04	123.14	290.46	178.68	214.42

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarti Pharmalabs...

820.85

(-0.96%)

Accent Microcell...

592.50

(-3.92%)

Accretion Pharma...

182.10

(-3.80%)

Achyut Healthcar...

Advanced Enzyme ...

248.35

(-4.06%)

Akums Drugs & Ph...

669.00

(-1.65%)

Albert David Ltd

763.70

(-2.63%)

Alembic Pharmace...

760.10

(-2.71%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

RMM

R M Malla

Chairman & Independent Directo

Executive

Functional Directors

Varinder Gupta

Executive Director & MD

Exec.

Vikas Gupta

Executive Director / JMD / WTD

Exec.

Abhiraj Gupta

E D & Wholetime Director

Dir.

KKR

Kushal Kumar Rana

Executive Director (Works)

Exec.

Independent Directors

Harpal Singh

Independent Non Exe. Director

Ind.

SHARAD TYAGI

Independent Non Exe. Director

Ind.

Rajni Jha

Independent Non Exe. Director

Ind.

Company Secretary & Compliance

ARS

Abhay Raj Singh

SVP / Company Secretary / Compliance Officer

Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Iol Chemicals And Pharmaceuticals Ltd? −

Iol Chemicals And Pharmaceuticals Ltd trades on NSE under IOLCP and on BSE under code 524164. The ISIN is INE485C01029 and the face value is Rs 2.

What is the share price of Iol Chemicals And Pharmaceuticals Ltd today? +

As of 25 October 2026, Iol Chemicals And Pharmaceuticals Ltd trades at Rs 164.14, a change of -7.22 (-4.21%) on the day. Prices are live and subject to change.

What is the market capitalisation of Iol Chemicals And Pharmaceuticals Ltd? +

As of 25 October 2026, Iol Chemicals And Pharmaceuticals Ltd has a market cap of about Rs 4796.24 crore. This figure is live and moves with the share price.

Is Iol Chemicals And Pharmaceuticals Ltd profitable? +

In March 2026, Iol Chemicals And Pharmaceuticals Ltd reported a profit after tax of Rs 137.64 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Iol Chemicals And Pharmaceuticals Ltd? +

: As of 25 October 2026, the PE (TTM) for Iol Chemicals And Pharmaceuticals Ltd is 27.14 and the price-to-book ratio is 2.67. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Iol Chemicals And Pharmaceuticals Ltd pay a dividend? +

As of 25 October 2026, the dividend yield for Iol Chemicals And Pharmaceuticals Ltd is 0.61%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Iol Chemicals And Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 62.28% of Iol Chemicals And Pharmaceuticals Ltd. Public shareholding is 37.72%, including mutual funds at 0.29% and foreign institutional investors at 7.25%.

What were the latest annual financials of Iol Chemicals And Pharmaceuticals Ltd? +

In March 2026, Iol Chemicals And Pharmaceuticals Ltd reported net sales of Rs 2,319.06 crore, revenue growth of 11.54%, and earnings per share of Rs 4.69.